FDA: Sun’s Caraco Can Resume Some Operations at Two Michigan Facilities

Drug Industry Daily
A A
Sun Pharmaceuticals’ Caraco unit may resume some of its Detroit and Wixom, Mich., operations after recent FDA inspections show it is in compliance with a 2009 consent decree.

To View This Article:

Login

Subscribe To Drug Industry Daily